 |
|
| Blog results | Results 1 - 10 of about 1,541 for raloxifene patent. (0.47 seconds) |
| Sorted by relevance Sort by date |
| 25 Sep 2009 by Dr DK Sarwal In a partial viactory for generic player, Teva has been able to cut the patent protection of Raloxifene by almost 3 year. Also, both the parties can appeal against the said decision in higher court. Posted by Dr D.K Sarwal at 3:56 PM ... IP Pharma Doc - http://ippharmdoc.blogspot.com/ [ More results from IP Pharma Doc ] |
| 16 Nov 2009 by David Gorski And since cancer can take decades to develop, by the time a study concludes, a drug's patent life may be over. It is not a pretty picture, Dr. Vogel said. “You have to think that in boardrooms they are saying, Man, did we learn a lesson ... Science-Based Medicine - http://www.sciencebasedmedicine.org/ - References |
| 1 Nov 2009 by Caleb The human children lifespan is medical and even according a injury medicine of the patent of 4 bear per character. Magic, school and pressure are mutations of derivatives and properties of outlook made within cells. ... allisonqo5466 - http://allisonqo5466.blogspot.com/ |
| 18 Apr 2006 by Bill Because an estimated 500000 women use raloxifene to reduce the risk of osteoporosis, many will be more comfortable using it for breast cancer protection, several experts predicted. .... And how crazy is it that - from what I've read - at least one of the HRT therapies was modified in structure from bioidentical hormones to ... wait for it ... wait for it ... establish a drug that had the hormone-like effects, but was unique enough to hold an exclusive patent on. ... INDCJournal - http://www.indcjournal.com/ |
| 5 Oct 2009 by Net Guru Evista, in which the key ingredient is raloxifene, generated $1.08 billion in global sales last year, the company reported Jan. 29. That includes $700.5 million, or an average of almost $2 million a day, in the US ... Pharmaceutical News Live - http://pharmanewslive.blogspot.com/ |
| 14 Sep 2009 by Jessica Brown reg-lilly- (eli) & c_o: evista+ patent litig_ation -_ pi granted | re_ute,rsbest price of r-ocaltrol, (calcitriol) -generic+ and bran-d pillsbio-or_gan_ics : glu-cosamine sulfa,te complex 10.00 'with bioacti,ve . ... how to stop breast feeding - complete report - http://how-to-stop-breastfeeding.blogspot.com/ |
| 13 Sep 2009 by IklanNews1 promo-ting -healthy bones+arava t'he jewish en'vironmental e_xperience on k,ibbutz* lotanreg-l-illy (e*li) & co: ,evista patent li*ti.gation - pi grante,d _| reutersa topic'al cre-am containing 'gluco+samine and c-hondroi'tin sulpha_te ... Ketawablog - http://ketawablog.blogspot.com/ |
| 16 Nov 2009 Moreover, in general for prevention the usual course of tamoxifen or raloxifene is five years, in marked contrast to supplements, where the woo-meisters recommend them for the rest of one's life. ... And since cancer can take decades to develop, by the time a study concludes, a drug's patent life may be over. It is not a pretty picture, Dr. Vogel said. "You have to think that in boardrooms they are saying, Man, did we learn a lesson," he said. "We will stay as far away as ... Respectful Insolence - http://scienceblogs.com/insolence/ - References |
| 14 Sep 2009 by eswa patent litig,ation - pi 'granted | r_eutersnutr+i+tion diva :: diet f.or' healthy -bonesdidro,nel - definition' of *didronel in the med_ic,al dictiona+ry - by ..+.o6ez_buy_rocaltr,ol_on+line_cheap - mo_ngre*l - tracus dru'gs - buy ... Indian Hot Masala - Exposing The Fasion - http://indian-hotpics.blogspot.com/ |
| 21 Jun 2009 by Patent Docs The patent at issue, Canadian Patent No. 2101356 ('356 patent) is directed to the use of a group of compounds (including raloxifene) in the treatment or prevention of osteoporosis and for inhibiting bone loss in a human. ... Patent Docs - http://www.patentdocs.org/ - References [ More results from Patent Docs ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
